ARCHIVES

Benefit Seen In Novel Drug That Treats Gleevec Resistance

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Waxman Adds NIH Bypass Budget To Authorization Bill, OKs$1.32 Billion for NCI In FY 1984

April 1, 1983

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

Cooperative Groups: Decision To Form One Group Seemed “So Obvious”

August 7, 1998

In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions

October 22, 1993